Showing results (121-130 of 377) with videos related to
Sort By:
Pageof 38
Zeitschrift Fur Rheumatologie|January 14, 2018
[Lymphoma in rheumatic diseases]A Rubbert-Roth, J T Bittenbring, G AssmannClinical Chemistry|September 23, 1997
Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assaysR Junker, B Brandt, C Zechel, et al.The Journal of Biological Chemistry|December 10, 1999
Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout miceF Kannenberg, P Ellinghaus, G Assmann, et al.Atherosclerosis|July 31, 1999
Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individualsG Hergenç, H Schulte, G Assmann, et al.Gut|March 1, 1979
Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytesU Hopf, G Assmann, H E Schaefer, et al.Biochimica Et Biophysica Acta|July 17, 1999
Stability and binding properties of wild-type and c17s mutated human sterol carrier protein 2C Jatzke, H J Hinz, U Seedorf, et al.Journal of Lipid Research|February 1, 1984
Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteinsM Rosseneu, G Assmann, M J Taveirne, et al.Atherosclerosis|July 1, 1996
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transportG Assmann, H Schulte, A von Eckardstein, et al.Leber, Magen, Darm|December 1, 1981
[Cholesteryl ester storage disease in the liver (author's transl)]H D Kuntz, B May, V Schejbal, et al.The Journal of Clinical Investigation|November 1, 1977
Characterization of high density lipoproteins in patients heterozygous for Tangier diseaseG Assmann, O Simantke, H E Schaefer, et al.Pageof 38